GM1 ganglioside may slow symptom progression in Parkinson's disease patients

被引：0
作者：
Freeston, Sarah [1 ]
机构：
[1] Future Med Ltd, Neurodegenerat Dis Management, Unitec House,2 Albert Pl, London N3 1QB, England
来源：
NEURODEGENERATIVE DISEASE MANAGEMENT | 2013年 / 3卷 / 01期
关键词：
D O I：
10.2217/NMT.13.3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
[21]   GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease [J].
Jay S. Schneider ;
Radha Aras ;
Courtney K. Williams ;
James B. Koprich ;
Jonathan M. Brotchie ;
Vikrant Singh .
Scientific Reports, 9
[22]   GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease [J].
Schneider, Jay S. ;
Aras, Radha ;
Williams, Courtney K. ;
Koprich, James B. ;
Brotchie, Jonathan M. ;
Singh, Vikrant .
SCIENTIFIC REPORTS, 2019, 9 (1)
[23]   Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review [J].
Zhang, Wenchao ;
Krafft, Paul R. ;
Wang, Tianlong ;
Zhang, John H. ;
Li, Li ;
Tang, Jiping .
CELL TRANSPLANTATION, 2019, 28 (06) :657-661
[24]   Improvement of Parkinson's disease patients after GM1 ganglioside treatment: A double blind placebo-controlled study [J].
Schneider, JS ;
Roeltgen, DP ;
Mancall, EL ;
Crilly, J ;
Rothblat, DS ;
Tatarian, GT .
NEUROLOGY, 1997, 48 (03) :2003-2003
[25]   PROPERTIES OF ANTISERA TO GANGLIOSIDE GM1 AND ASIALO GM1 [J].
NAIKI, M ;
MARCUS, DM ;
LEDEEN, R .
JOURNAL OF IMMUNOLOGY, 1974, 113 (01) :84-93
[26]   Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson's disease; successful treatment with synthetic GM1 ganglioside [J].
Wu, Gusheng ;
Lu, Zi-Hua ;
Seo, Joon Ho ;
Alselehdar, Samar K. ;
DeFrees, Shawn ;
Ledeen, Robert W. .
EXPERIMENTAL NEUROLOGY, 2020, 329
[27]   Parkinson's disease - Improved function with GM1 ganglioside treatment in a randomized placebo-controlled study [J].
Schneider, JS ;
Roeltgen, DP ;
Mancall, EL ;
Chapas-Crilly, J ;
Rothblat, DS ;
Tatarian, GT .
NEUROLOGY, 1998, 50 (06) :1630-1636
[28]   Disease-modifying effects of ganglioside GM1 in Huntington's disease models [J].
Alpaugh, Melanie ;
Galleguillos, Danny ;
Forero, Juan ;
Morales, Luis Carlos ;
Lackey, Sebastian W. ;
Kar, Preeti ;
Di Pardo, Alba ;
Holt, Andrew ;
Kerr, Bradley J. ;
Todd, Kathryn G. ;
Baker, Glen B. ;
Fouad, Karim ;
Sipione, Simonetta .
EMBO MOLECULAR MEDICINE, 2017, 9 (11) :1537-1557
[29]   Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1 [J].
Maglione, Vittorio ;
Marchi, Paolo ;
Di Pardo, Alba ;
Lingrell, Susanne ;
Horkey, Melanie ;
Tidmarsh, Emily ;
Sipione, Simonetta .
JOURNAL OF NEUROSCIENCE, 2010, 30 (11) :4072-4080
[30]   Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease [J].
Guo, Yu-Lin ;
Duan, Wen-Jun ;
Lu, Dan-Hua ;
Ma, Xiao-Hui ;
Li, Xiao-Xiao ;
Li, Zhao ;
Bi, Wei ;
Kurihara, Hiroshi ;
Liu, Hai-Zhi ;
Li, Yi-Fang ;
He, Rong-Rong .
ACTA PHARMACOLOGICA SINICA, 2021, 42 (04) :518-528
12345